SCHEMBL12698682

SCHEMBL12698682

Nc1ccc(C(=O)N2CCN(C(=O)c3cn[nH]c3)CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.54
CA1 P00915 4/20 0.54
CA2 P00918 4/20 0.54
CA7 P43166 4/20 0.54
CA9 Q16790 4/20 0.54
CA14 Q9ULX7 4/20 0.54
MGLL Q99685 1/20 0.45
RIPK1 Q13546 1/20 0.45
ALDH1A1 P00352 2/20 0.43
HPGD P15428 1/20 0.43
CCNC P24863 1/20 0.42
CDK8 P49336 1/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PAK1 Q13153 4/20 0.40
PROKR1 Q8TCW9 1/20 0.40
JAK1 P23458 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20261717 0.82 CA12 (0.73) CA12CA1CA2CA7CA9
SCHEMBL3310693 0.80 HPGD (0.52) RIPK1ALDH1A1HPGDMEN1KMT2A
SCHEMBL21259942 0.80 PROKR1 (0.47) RIPK1ALDH1A1HPGDMEN1LMNA
SCHEMBL13751474 0.80 POLB (0.50) RIPK1HPGDMEN1KMT2A
SCHEMBL17276467 0.79 HPGD (0.55) CA12CA1CA2CA7CA9
SCHEMBL28471523 0.78 RIPK1 (0.45) RIPK1ALDH1A1HPGDMEN1KMT2A
SCHEMBL1178863 0.76 SMN1; SMN2 (0.53) RIPK1ALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL13741680 0.76 HRH3 (0.50)
SCHEMBL18753791 0.75 CA12 (0.65) CA12CA1CA2CA7CA9
SCHEMBL1512436 0.75 CA12 (0.65) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012151452-A1 PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY AGIOS PHARMACEUTICALS, INC (US) 2012-11-08 WO disclosed
WO-2012092442-A1 THERAPEUTIC COMPOUNDS AND COMPOSITIONS AGIOS PHARMACEUTICALS, INC. (US) 2012-07-05 WO disclosed